NIOX Group plc clinical trials

Also known as Circassia.

The registry lists 43 studies whose lead sponsor is NIOX Group plc or one of 3 companies grouped under it. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jun 15, 2018.

Studies

Recruiting first, then most recently updated. Showing 43 of 43.

• Phase III Cat-PAD Follow-on StudyCompletedNCT02040844Phase 3

  Sponsor listed in the registry: Circassia Limited

• Phase III Cat-PAD StudyCompletedNCT01620762Phase 3

  Sponsor listed in the registry: Circassia Limited

• Phase II HDM-SPIRE Safety and Efficacy StudyCompletedNCT02150343Phase 2

  Sponsor listed in the registry: Circassia Limited

• Paediatric Safety Study in Cat-PADCompletedNCT01921257Phase 2

  Sponsor listed in the registry: Circassia Limited

• Measurement of FeNO in Young Children With the NIOX VEROStatus unknownNCT02661984

  Sponsor listed in the registry: Aerocrine AB · First submitted after Aerocrine AB became part of NIOX Group plc

• NIOX VERO Nasal Application in Primary Ciliary DyskinesiaCompletedNCT02622061

  Sponsor listed in the registry: Aerocrine AB · First submitted after Aerocrine AB became part of NIOX Group plc

• Birch-SPIRE Safety and Efficacy StudyCompletedNCT02478060Phase 2

  Sponsor listed in the registry: Circassia Limited

• Efficacy and Safety of Grass-SPIRE Registration StudyWithdrawnNCT02795273Phase 2/3

  Sponsor listed in the registry: Circassia Limited

• Dose Ranging Study of Glycopyrronium Bromide in Patients With Moderate or Severe Chronic Obstructive Pulmonary DiseaseCompletedNCT01703624Phase 2

  Sponsor listed in the registry: Prosonix Limited · First submitted before Prosonix Limited became part of NIOX Group plc

• Ragweed-SPIRE Follow-On StudyCompletedNCT02396680

  Sponsor listed in the registry: Circassia Limited

• Grass Observational StudyCompletedNCT02075138

  Sponsor listed in the registry: Circassia Limited

• Study of Grass-SPIRE in Subjects With Grass Allergies and AsthmaCompletedNCT02161107Phase 2

  Sponsor listed in the registry: Circassia Limited

• Evaluating the Efficacy of Ragweed-SPIRE Following Exposure to Ragweed Allergen in an Environmental Exposure ChamberCompletedNCT02061709Phase 2

  Sponsor listed in the registry: Circassia Limited

• Safety Study of Ragweed-SPIRE in Subjects With Ragweed Allergies and AsthmaCompletedNCT02061670Phase 2

  Sponsor listed in the registry: Circassia Limited

• ToleroMune Grass Follow on StudyCompletedNCT02292875

  Sponsor listed in the registry: Circassia Limited

• ToleroMune House Dust Mite (HDM) Tolerability StudyCompletedNCT01949441Phase 2

  Sponsor listed in the registry: Circassia Limited

• Identification of Potential Biomarkers of Peptide Immunotherapy. Part 2 - Gene Array AnalysisCompletedNCT01383603Phase 1

  Sponsor listed in the registry: Circassia Limited

• An Optional Investigation of Biomarkers of EfficacyCompletedNCT01949415

  Sponsor listed in the registry: Circassia Limited

• ToleroMune House Dust Mite Follow on StudyCompletedNCT01923792

  Sponsor listed in the registry: Circassia Limited

• House Dust Mite Observational StudyCompletedNCT01949428

  Sponsor listed in the registry: Circassia Limited

• A Study to Explore the Utility of Fractional Exhaled Nitric Oxide (FeNO) Compared With Methacholine Challenge (MCC) Testing in the Assessment of Patients With Suspected But Undiagnosed AsthmaCompletedNCT01648920

  Sponsor listed in the registry: Aerocrine AB · First submitted before Aerocrine AB became part of NIOX Group plc

• Study to Evaluate the Impact of FeNO Assessments on Asthma Management Decisions in Subject 7 to 60 Years of AgeCompletedNCT01729247

  Sponsor listed in the registry: Aerocrine AB · First submitted before Aerocrine AB became part of NIOX Group plc

• Use of FeNO to Identify Eosinophilic Inflammation in Patients Age 40 Years and Above With Chronic Obstructive Airways DiseaseCompletedNCT01634620

  Sponsor listed in the registry: Aerocrine AB · First submitted before Aerocrine AB became part of NIOX Group plc

• Identification of Potential Biomarkers of Peptide Immunotherapy. Part 1 - Proteomics AnalysisCompletedNCT01383590Phase 1

  Sponsor listed in the registry: Circassia Limited

• ToleroMune Grass Follow on StudyCompletedNCT01923779

  Sponsor listed in the registry: Circassia Limited

• Impact of FeNO Measured With the NIOX MINO® Device in Identifying Asthma Among Patients With Prolonged Respiratory SymptomsCompletedNCT01518322

  Sponsor listed in the registry: Aerocrine AB · First submitted before Aerocrine AB became part of NIOX Group plc

• ToleroMune Grass Exposure Unit StudyCompletedNCT01385800Phase 2

  Sponsor listed in the registry: Circassia Limited

• Antipsoriatic Effect of a Topical Formulation for the Treatment of Psoriasis VulgarisCompletedNCT01743118Phase 1

  Sponsor listed in the registry: Circassia Limited

• ToleroMune House Dust Mites (HDM) Exposure Chamber StudyCompletedNCT01447784Phase 2

  Sponsor listed in the registry: Circassia Limited

• An Optional Two Year Follow Up Study to Study CP005ACompletedNCT01604018

  Sponsor listed in the registry: Circassia Limited

• ToleroMune Ragweed Follow up StudyCompletedNCT01448603

  Sponsor listed in the registry: Circassia Limited

• Study of Monitoring Exhaled NO in Symptomatic Asthmatic Adults and Children During Anti-inflammatory TreatmentCompletedNCT00388570Not applicable

  Sponsor listed in the registry: Aerocrine AB · First submitted before Aerocrine AB became part of NIOX Group plc

• Ragweed Observational StudyCompletedNCT01398137

  Sponsor listed in the registry: Circassia Limited

• Identification of Potential Biomarkers of Response to Peptide Immunotherapy for Ragweed AllergyCompletedNCT01361412Phase 2

  Sponsor listed in the registry: Circassia Limited

• ToleroMune Ragweed Exposure Chamber StudyCompletedNCT01198613Phase 2

  Sponsor listed in the registry: Circassia Limited

• Cat-PAD Follow on StudyCompletedNCT01272323

  Sponsor listed in the registry: Circassia Limited

• Safety and Tolerability of ToleroMune Grass in Grass Allergic Subjects With RhinoconjunctivitisCompletedNCT01166061Phase 2

  Sponsor listed in the registry: Circassia Limited

• Safety of ToleroMune Ragweed to Treat Ragweed Allergy in Ragweed Allergic Subjects With RhinoconjunctivitisCompletedNCT00878774Phase 2

  Sponsor listed in the registry: Circassia Limited

• Safety of ToleroMune House Dust Mite (HDM) to Treat House Dust Mite Allergy in HDM Allergic Subjects With RhinoconjunctivitisCompletedNCT01008332Phase 2

  Sponsor listed in the registry: Circassia Limited

• Cat-PAD Exposure Chamber StudyCompletedNCT01033344Phase 2

  Sponsor listed in the registry: Circassia Limited

• Safety of Cat-PAD to Treat Cat Allergy in Cat Allergic Subjects With Controlled AsthmaCompletedNCT00867906Phase 2

  Sponsor listed in the registry: Circassia Limited

• Effectiveness of Cat-PAD to Treat Cat Allergy in Cat Allergic SubjectsCompletedNCT00729508Phase 2

  Sponsor listed in the registry: Circassia Limited

• Safety of Cat-PAD in Cat Allergic SubjectsCompletedNCT00685711Phase 1/2

  Sponsor listed in the registry: Circassia Limited